8-K: Hillenbrand Reports Q3 2025 Earnings Amid Macro Headwinds
Quarterly Earnings Report
Hillenbrand, Inc. reported fiscal third quarter 2025 results with revenue ahead and adjusted EPS in line with expectations, despite significant year-over-year declines.
Summary
- Net revenue for the fiscal third quarter ended June 30, 2025, was $598.9 million, a 24% decrease compared to the prior year, primarily due to the divestiture of the MIME business and lower capital equipment volume in APS.
- Pro forma net revenue decreased 10% year-over-year.
- GAAP net income attributable to Hillenbrand was $1.9 million ($0.03 per diluted share), a significant increase from a loss of $(248.9) million ($(3.53) per diluted share) in the prior year, mainly due to a non-cash impairment charge recorded in the prior fiscal year.
- Adjusted diluted EPS was $0.51, a 40% decrease from $0.85 in the prior year, primarily due to the MIME divestiture and lower volume.
- Adjusted EBITDA was $84.3 million, down 36% year-over-year, with pro forma adjusted EBITDA down 28%.
- Cash flows from operating activities represented a use of $1.5 million in the quarter, compared to a positive $45.6 million in the prior year.
- Achieved $30 million of run-rate cost synergies associated with the Linxis and FPM acquisitions earlier than planned.
- Reduced debt by over $300 million during the fiscal year using proceeds from the MIME divestiture and the sale of a minority interest in TerraSource.
- On July 1, 2025, completed the divestiture of a minority stake in TerraSource, receiving approximately $115 million used for debt pay down.
- On July 22, 2025, redeemed $375 million notes due September 2026 and successfully amended and extended syndicated credit facilities.
- Fiscal 2025 outlook updated for core business, maintaining the midpoint of the full-year adjusted EPS range.
Sentiment
Score: 6
Explanation: The company reported significant year-over-year declines in revenue and adjusted EPS, and negative operating cash flow. However, GAAP net income saw a substantial turnaround due to the absence of prior-year impairment charges. Management successfully executed strategic divestitures, achieved synergy targets ahead of schedule, and significantly reduced debt, while also meeting or exceeding internal expectations for the quarter. The maintained full-year adjusted EPS outlook suggests resilience despite macroeconomic challenges.
Positives
- GAAP net income significantly improved to $1.9 million ($0.03 EPS) from a loss of $(248.9) million ($(3.53) EPS) in the prior year, largely due to the absence of a prior-year impairment charge.
- Achieved $30 million in run-rate cost synergies from Linxis and FPM acquisitions earlier than planned.
- Successfully reduced debt by over $300 million during the fiscal year through strategic divestitures.
- Completed the divestiture of a minority stake in TerraSource for approximately $115 million, further reducing debt and improving net leverage to 3.7x.
- Redeemed $375 million notes due September 2026, optimizing the capital structure and enhancing financial flexibility.
- Amended and extended syndicated credit facilities, providing greater operational and financial flexibility.
- Delivered revenue ahead of and adjusted EPS in line with internal expectations for the quarter.
Negatives
- Net revenue decreased 24% year-over-year to $598.9 million, with pro forma net revenue down 10%.
- Adjusted diluted EPS decreased 40% year-over-year to $0.51.
- Adjusted EBITDA decreased 36% year-over-year, with pro forma adjusted EBITDA down 28%.
- Cash flows from operating activities were a use of $1.5 million, a significant decline from $45.6 million in the prior year, primarily due to lower customer advances from decreased order volume.
- Advanced Process Solutions (APS) net revenue decreased 11% and adjusted EBITDA decreased 27% due to lower capital equipment volume, unfavorable product mix, and inflation.
- Molding Technology Solutions (MTS) pro forma net revenue decreased 2% and pro forma adjusted EBITDA decreased 9% due to lower volumes, inflation, and tariffs.
- APS backlog decreased 10% compared to the prior year, primarily due to lower capital equipment order intake.
- Customers continue to delay purchasing decisions due to the dynamic tariff landscape and macroeconomic conditions.
Risks
- Global market and economic conditions, including volatility in financial markets, U.S. presidential election, and new U.S. administration's tariffs and trade policies.
- Business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure.
- Increasing competition for highly skilled and talented workers, as well as labor shortages.
- Closures or slowdowns and changes in labor costs and labor difficulties.
- Uncertainty related to environmental regulation and industry standards, as well as physical risks of climate change.
- Increased costs, poor quality, or unavailability of raw materials or certain outsourced services and supply chain disruptions.
- Economic and financial conditions including volatility in interest and exchange rates, commodity and equity prices and the value of financial assets.
- Uncertainty in U.S. global trade policy and risks with governmental instability in certain parts of the world.
- Level of international sales and operations.
- Negative effects of acquisitions, including Schenck Process Food and Performance Materials (FPM) business and Linxis Group SAS (Linxis) acquisitions, on the Company's business, financial condition, results of operations and financial performance.
- Competition in the industries in which the Company operates, including on price.
- Cyclical demand for industrial capital goods.
- Ability to recognize the benefits of any acquisition or divestiture, including potential synergies and cost savings.
- Potential adverse effects of the announcement or results of the Milacron injection molding and extrusion business sale on the market price of the Company's common stock or on relationships with personnel, customers, and suppliers.
- Risks related to diversion of management's attention from ongoing business operations due to transactions.
- Impacts of decreases in demand or changes in technological advances, laws, or regulation on net revenues derived from the plastics industry.
- Impact to the Company's effective tax rate of changes in the mix of earnings or in tax laws and certain other tax-related matters.
- Exposure to tax uncertainties and audits.
- Involvement in claims, lawsuits, and governmental proceedings related to operations.
- Uncertainty in the U.S. political and regulatory environment.
- Adverse foreign currency fluctuations.
- Labor disruptions.
Future Outlook
Hillenbrand is updating its core outlook for fiscal year 2025, maintaining the midpoint of its full-year adjusted EPS range ($2.20 $2.35) based on year-to-date performance and its outlook for the fiscal fourth quarter. The company projects net revenue between $2,595 million and $2,630 million, adjusted EBITDA between $370 million and $385 million, operating cash flow of approximately $60 million, and capital expenditures of approximately $40 million.
Management Comments
- "We continued to advance our strategic initiatives this quarter, including refining our portfolio, reducing debt, and advancing the integration and commercial synergy potential of our Food, Health, and Nutrition (FHN) business, despite the ongoing uncertainty stemming from macroeconomic conditions and tariffs."
- "We used proceeds from the MIME divestiture and the sale of our minority interest in TerraSource to reduce debt by over $300 million during the fiscal year."
- "These portfolio moves allow us to focus on our higher margin, higher growth, and higher ROIC businesses serving the performance materials and FHN end markets."
- "Within our FHN business, we recently achieved the $30 million in run-rate cost synergies from the Linxis and FPM acquisitions, and over the last several quarters we are beginning to see the proof points of the combined assets commercial synergy potential."
- "During our fiscal third quarter, we delivered revenue ahead of and adjusted EPS in line with our expectations, despite customers continuing to delay purchasing decisions due to the dynamic tariff landscape."
- "I am grateful for our teams, who took quick and deliberate action to mitigate these impacts through our in-region for-region approach and other initiatives we outlined."
- "I remain confident our durable business segments, our differentiated technologies, and our people will continue to deliver best-in-class systems and solutions to our customers around the world."
Industry Context
The company's performance is influenced by ongoing uncertainty stemming from macroeconomic conditions and tariffs, which have led customers to delay purchasing decisions. Despite these headwinds, the company is strategically refining its portfolio to focus on higher-margin, higher-growth businesses in performance materials and food, health, and nutrition end markets.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or industry benchmarks to assess the results against global standards.
Stakeholder Impact
- Shareholders: Impacted by decreased adjusted EPS and revenue, but potentially benefit from strategic portfolio refinement, debt reduction, and improved capital structure.
- Creditors: Benefit from significant debt reduction and successful amendment/extension of credit facilities, improving the company's financial flexibility and leverage ratio.
- Employees: The company's strategic initiatives and focus on higher-growth businesses could provide long-term stability, but macroeconomic conditions and restructuring efforts may pose challenges.
- Customers: May experience delays in purchasing decisions due to tariffs and macroeconomic uncertainty, impacting order volumes.
- Suppliers: Could be affected by lower capital equipment volume and supply chain disruptions mentioned as a risk.
Next Steps
- The company expects to file its financial statements on Form 10-Q jointly with this release.
- A conference call and simultaneous webcast will be held on August 12, 2025, at 8:00 a.m. ET to discuss the results.
Key Dates
| Date | Description |
|---|---|
| 2024-03-31 | Milacron injection molding and extrusion business divested. |
| 2024-04-29 | Form 10-Q for the quarter ended March 31, 2025, filed with the SEC. |
| 2024-09-30 | Fiscal year end for which Form 10-K was filed on November 19, 2024. |
| 2024-11-19 | Form 10-K for the year ended September 30, 2024, filed with the SEC. |
| 2025-06-30 | End of fiscal third quarter for which results are reported. |
| 2025-07-01 | Divestiture of minority stake interest in TerraSource completed. |
| 2025-07-22 | Redemption in full of $375 million notes due September 2026 and amendment/extension of syndicated credit agreement and L/G facility agreement. |
| 2025-08-11 | Date of earnings announcement and press release issuance. |
| 2025-08-12 | Conference call and simultaneous webcast for Q3 2025 earnings at 8 a.m. EST. |
| 2025-08-26 | Conference call replay available until midnight ET. |
| 2026-09-01 | Maturity date of $375 million notes that were redeemed on July 22, 2025. |
Recommendation
holdWhile Hillenbrand demonstrated strong execution on strategic initiatives like debt reduction and synergy achievement, and met/exceeded internal expectations for the quarter, the significant year-over-year declines in revenue and adjusted EPS, coupled with negative operating cash flow and ongoing macroeconomic headwinds, present a mixed picture. The maintained full-year adjusted EPS outlook provides some stability, but the overall environment suggests a 'hold' position until clearer signs of sustained revenue and earnings growth emerge.
Keywords
Industrial Equipment, Processing Equipment, Manufacturing, Plastics, Food Processing, Nutrition, Performance Materials, SEC Filing, Earnings Report, Financial Results, Debt Reduction, Divestiture, Synergies, Capital Equipment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.